CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Green Receipt who wrote (508)	4/27/1999 6:47:00 AM
From: Mike McFarland	Read Replies (1) of 675

If you go to the links in the left frame it will take you to the full document... took me awhile to figure that out. 14.6% is the number apparently. It is reassuring to see a fund invest in this. while I am here, I'll drop of a couple urls I found somewhat interesting. remyelination AMPA?? The lab is examining the molecular mechanisms of growth factor mediate myelination. A second focus is the role of AMPA and kainate type-excitatory amino acid receptors in regulating myelination and in the cross-talk between axons and oligodendrocytes. neuro.wustl.edu Buy the book: Molecular Signaling and Regulation in Glial Cells A Key to Remyelination and Functional Repair springer-ny.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next